A pioneering step to prevent heart disease in under 5 minutes — even before symptoms appear
Mumbai, 19th July, 2025 (TGN ) : In a landmark initiative that could redefine how India tackles its leading cause of death, Jaslok Hospital & Research Centre has partnered with AnginaX AI, India’s first licensed AI Doctor Assistant in cardiology, to launch Maharashtra’s first operational AI-powered heart prevention model.
This collaboration places Jaslok at the forefront of India’s shift from late-stage cardiac intervention to early, technology-driven prevention. The advanced AnginaX AI system, now deployed across Jaslok’s outpatient departments, enables doctors to assess cardiovascular risk in just seconds — using structured, science-backed reports that identify risk even before symptoms appear and recommend personalised lifestyle and treatment plans.
With heart disease affecting millions of Indians and often going undetected until it’s too late, this prevention model brings speed, clarity, and access to the very first point of contact: the OPD.
“For decades, cardiology has focused on damage control,” said Padma Bhushan Awardee Dr. Ashwin B. Mehta, Director of Cardiology at Jaslok Hospital.
“But with advanced AI, we can now assess who is at risk before damage begins. This is not just innovation, but reimagining the timeline of care.”
The AnginaX system evaluates over 20+ critical clinical and lifestyle-based indicators, including extended lipid profiles, blood sugar, inflammatory biomarkers, metabolic complexities, family history, and lifestyle patterns. Based on validated Indian data, the system generates a structured clinical summary that includes individualised risk stratification, investigation recommendations specific to each patient, and clear, actionable treatment and follow-up guidance.
“The AnginaX AI system gives us clinical clarity in under a minute — especially vital in high-volume OPD settings,” said Dr. Ajit Desai, Senior Cardiologist at Jaslok.
“We’re now able to consult more patients, detect silent risks early, and guide people to act before their first symptom.”
Recognising that cost and fear are often barriers to early checkups, Jaslok and AnginaX have ensured the program is fast, accessible, and affordable — making prevention routine rather than rare.
Jaslok Hospital Leads Maharashtra’s AI-Driven Prevention Movement. “This isn’t just about digital transformation, but about medical timing,” said Mr. Jitendra Haryan, CEO of Jaslok Hospital. “Our hospital is proud to lead this change in India’s healthcare system. When technology and medicine work together, lives are saved earlier.”
Jaslok also launched AI-powered initiative “Dil Fit, Life Hit” under the leadership of Dr. Ashwin B. Mehta, bringing structured cardiovascular prevention into everyday clinical care. The program empowers doctors, transforms OPD practice, and makes prevention accessible to every patient — not just those with symptoms.
Naman Gosalia, Founder of AnginaX AI, added: “We’ve built an advanced AI medical system that fits seamlessly into any hospital or clinic, helping doctors halt the progression of cardiovascular disease through precision-led risk assessment and personalised treatment recommendations. Our mission is to bring primary prevention to every clinic, every hospital, every corner of India; without disrupting how doctors practice.”
“The KPI of this model was simple: could it work on my own mother? We made a clear decision that we would only release it if it worked on her. We tested it on our mother first before going into pilot. That trial was successful, and it gave us the conviction to move forward,” he said.
“Launching it at Jaslok and having their leadership activate it first in Maharashtra; reflects a shared belief that people deserve better outcomes, and prevention should not come with fear, friction, or financial burden. This partnership helps us put the patient first and take this mission to scale across India.”
AI-based screening has already begun at Jaslok. Doctors are now taking swift, informed preventive steps, especially for patients who might otherwise remain undiagnosed until a critical event occurs.
